Examiner Iyabo S. Alli
Grant ratio: 82.3% (91st percentile in Art Unit 2877 among examiners with at least 20 applications). Average office actions per grant: 1.54. Most common rejection type: §103.
Appears inactive
Last office action in data: March 2016
Examiner record
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 54 | 58.5% | 1.47 |
| Group | 352 | 60.7% | 1.71 |
| Tech Center | 2,428 | 61.6% | 1.69 |
| USPTO | 16,572 | 52.1% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 0 | 0.0% |
| 1 OA | 219 | 56.9% |
| 2 OAs | 139 | 36.1% |
| 3 OAs | 24 | 6.2% |
| 4 OAs | 2 | 0.5% |
| 5+ OAs | 1 | 0.3% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2008 | 39 | 25 | 64.1% |
| 2009 | 75 | 60 | 80.0% |
| 2010 | 70 | 61 | 87.1% |
| 2011 | 62 | 56 | 90.3% |
| 2012 | 50 | 42 | 84.0% |
| 2013 | 24 | 19 | 79.2% |
| 2014 | 27 | 20 | 74.1% |
| 2015 | 35 | 31 | 88.6% |
| 2016 | 3 | 3 | 100.0% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 385 | 0.0% | 10.6% | 85.2% | 0.3% |
| Action 2 | 166 | 0.6% | 5.4% | 92.8% | 0.6% |
| Action 3 | 27 | 0.0% | 7.4% | 92.6% | 0.0% |
| Action 4 | 3 | 0.0% | 0.0% | 100.0% | 0.0% |
| Action 5 | 1 | 0.0% | 0.0% | 100.0% | 0.0% |
Section 101 rejections
Last 3 years: 2023-10-02–2026-10-02. All years includes every dated office action in the data.
By year
0.0%
0.8%
0.0%
0.0%
0.0%
0.0%
2014: Alice
0.0%
0.0%
0.0%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Oct. 9, 2026.